← Back to Search

Behavioural Intervention

Exercise for Cancer Patients at High Risk of Falls

Phase 1
Recruiting
Led By Aminah Jatoi, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any cancer diagnosis, as documented in medical record, other than non-melanoma skin cancer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline abc scale at 4-6 weeks
Awards & highlights

Study Summary

This trial is testing whether cancer patients who exercise are less likely to fall and injure themselves.

Who is the study for?
This trial is for cancer patients, except those with non-melanoma skin cancer. Participants should be able to exercise without restrictions like unstable heart conditions or loss of a limb that would make exercising difficult.Check my eligibility
What is being tested?
The study tests an 'exercise prescription' approach using tools like a Perturbation Treadmill, Pedometer, and Actigraph to see if it can reduce falls in high-risk cancer patients by improving muscle strength.See study design
What are the potential side effects?
While the trial itself may not have direct side effects, exercise routines could potentially cause muscle soreness, fatigue, or fall-related injuries if not properly supervised.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with cancer, other than non-melanoma skin cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline abc scale at 4-6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline abc scale at 4-6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ABC Activities Specific Balance Confidence Scale (exploratory outcome)

Trial Design

5Treatment groups
Experimental Treatment
Group I: 80%Experimental Treatment3 Interventions
Increase exercise daily step count by 80% above individual baseline.
Group II: 50%Experimental Treatment3 Interventions
Increase exercise daily step count by 50% above individual baseline.
Group III: 30%Experimental Treatment3 Interventions
Increase exercise daily step count by 30% above individual baseline.
Group IV: 20%Experimental Treatment3 Interventions
Increase exercise daily step count by 20% above individual baseline.
Group V: 10%Experimental Treatment3 Interventions
Increase exercise daily step count by 10% above individual baseline.

Find a Location

Who is running the clinical trial?

Andersen FoundationUNKNOWN
1 Previous Clinical Trials
63 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,212 Previous Clinical Trials
3,766,966 Total Patients Enrolled
Aminah Jatoi, M.D.Principal Investigator - Mayo Clinic
Mayo Clinic Hospital-Rochester Saint Marys Campus, Mayo Clinic Rochester
University Of Texas Medical Branch Galveston (Medical School)
University Hosp Of Cleveland (Residency)
9 Previous Clinical Trials
327 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are currently registered for the trial?

"Indeed, the clinical trials website is indicating that this research project has resumed its search for participants. Initially posted on September 3rd 2020 and updated as recently as March 28th 2022, the study requires 72 individuals from 1 site to take part."

Answered by AI

Has the Actigraph received regulatory authorization from the U.S. Food and Drug Administration?

"Due to the limited data surrounding Actigraph's safety and efficacy, it has been rated 1 on a scale of 1-3."

Answered by AI

Is this research open to new participants?

"Affirmative. According to clinicaltrials.gov, this medical investigation is actively enrolling participants and has been updated since its initial posting on September 3rd 2020. The trial requires 72 volunteers at a single site."

Answered by AI
~10 spots leftby Dec 2024